Furthermore, we found that the TRPV1 variants expression levels strongly decreased in TRPV1 positive (TRPV1+) glioma samples (grade III and IV) (Table 3A), except for the TRPV1v3, which expression was maintained in grade IV TRPV1+ samples (Table 3A). The gene discussed is TRPV1; the disease is central nervous system cancer.